Michigan Political News & Notes is a weekly look at what’s happening in Lansing and around the state. Here is a compilation of some of the week’s biggest headlines: House GOP school aid budget ...

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

The proposal should be withdrawn. It is untethered to the Inflation Reduction Act and science and undercuts the incentive to ...

Key pharma reforms are up in the air as Republicans battle over their mammoth legislation that includes significant ...

The president promised lower prices on medications for Americans, but the state's independent pharmacies doubt that will ...

This could force many local pharmacies to choose between stocking critical medications or keeping their doors open.

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

the Centers for Medicare and Medicaid Services (CMS) which oversees Medicare, announced the first 10 Part D drugs selected for pricing negotiations, which will lead to revised prices in 2026.

or about 14% of Medicare Part D’s prescription drug costs, according to CMS. The negotiated prices for the drugs will take effect in 2027. The second round of negotiations builds on the success ...

The Trump administration signaled Medicare drug price negotiations under the Inflation ... not total [Medicare parts B and D] spending,” Holz-Eakin told Health Care News. Under the IRA, CMS has the ...

The program, created under the Inflation Reduction Act (IRA), allows the federal government to negotiate the prices of some of the costliest Medicare Part D drugs directly with drug companies.

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input ...